Department of Pathology

Pathology Faculty

Nicholas T. Potter, Ph.D.

Clinical Associate Professor

Education
Duke University, Durham, NC, Ph.D., 1986
Research Associate, Department of Pathology, The University of Connecticut School of Medicine, Farmington, CT
Research Fellow, Department of Neurology, Harvard Medical School and Massachusetts General Hospital, Boston, MA
Research Associate, Eunice Kennedy Shriver Center for Mental Retardation, Waltham, MA

Certification
Diplomate, The American Board of Medical Genetics

Special Interests
Molecular Pathology/Molecular Diagnostics

Recent Publications

1. Nance MA, Potter NT, and the Ataxia Molecular Diagnostic Testing Group. Genetic Testing for ataxia: Lessons learned from 53,961 worldwide tests: Number and types of tests performed. Neurology 2002;58:A322.
2. Potter NT, Nance MA, and the Ataxia Molecular Diagnostic Testing Group Genetic Testing for ataxia and lessons learned from 53,475 worldwide tests: Diagnostic boundaries and trinucleotide repeat descriptors for ataxia gene testing. Genetics in Medicine 2002;4:231.
3. Holmes SE, O'Hearn E, Rosenblatt A, Callahan C, Hwang H, Brice A, Fleischer A, Potter NT, Ross CA, Margolis RL. Cloning and characterization of a CAG/CTG trinucleotide repeat expansion associated with a disorder similar to Huntington's disease. Am J Hum Genet 2001;69:2771.
4.  Ahearn ME, Potter N, Zoghbi H, Mater J, Bradley W, Baumbach L. Clinical and molecular investigation of 14 hereditary ataxia families: Mysteries remain. Genetics in Medicine 2001;3:245.
5. Moseley M, Jacobsen J, Liquori C, Durand A, Davis L, Ikeda Y, Bird T, Spiegel R, Ashizawa T, Pandolfo M, Potter N, Schaefer F, Milunski A, Kennedy A, Seltzer W, Attwood L, Vincent J, Day J, Ranum L. SCA8 CTG expansion: Evidence for a common haplotype and highly mutable region on both ataxia and non-ataxia chromosomes. Am J Hum Genet 2000;67:2032.
6. Aylsworth AS, Mao R, Wilson WG, Kaiser-Rogers K, Tennison MB, Silverman lm, -Snow K, Potter NT. Severe early onset of developmental retardation, cerebellar hypoplasia, and seizures in an infant with a maternally inherited extreme CAG-repeat expansion in the spinocerebellar ataxia type 2 (SCA2) gene. Am J Hum Genet 2000;67:242.
7. Ahearn ME, Potter N, Zoghbi H, Mater J, BradleyW, Baumbach L. Results of clinical and molecular evaluation of 14 hereditary ataxia families. Am J Hum Genet 2000;67:722.
8. Seltzer WK, Mclntosh N, Myers RH, for the US Huntington's Disease Genetic  Testing Group. How do US laboratories do Huntington Disease testing for at-risk individuals? Am J Hum Genet 1999;65:469.
9. Wick M, Allingham-Hawkins D, Nance MA, Potter NT, for the Ataxia Molecular Diagnostic Testing Group. Genetic testing for Friedreich Ataxia. Am J Hum Genet 1999;65:2335.
10. Potter NT, and Nance MA, for the Ataxia Molecular Diagnostic Testing Group Genetic testing for ataxia in North America. Am J HumGenet 1998; 63:1374.
11. Sequeiros J, Nance MA, for the Committee on Genetic Testing of the Ataxia Research Group (ARG) World Federation of Neurology (WFN). Offer and Utilization of genetic testing in the dominant ataxias: towards guidelines. Am J Hum Genet 1997;61:1316.
12. Pericak-Vance MA, Wolpert CM, Menold MM, Bass MP, DeLong GR, Beaty LM, Zimmerman A, Potter N, Gilbert JR, Vance JM, Wright HH, Abramson RK, Cuccaro ML. Linkage evidence supports the involvement of chromosome 15 in autistic disorder (AUT). Am J Hum Genet 1997;61:208.
13. Potter NT. Initial characterization of the CAGR1 gene product: A novel gene containing a meiotically unstable trinucleotide repeat. Am J Hum Genet 1997;61:1858.
14. Nance MA, and the US Huntington Disease Genetic Testing Group. Voluntary monitoring of predictive testing programs for Huntington disease: the United States Huntington Disease Genetic Testing Group (US HD GTG). Am J Hum Genet 1997;61:1302.
15. Visintainer C, Nance MA, and the US Huntington Disease Genetic Testing Group. Anonymous predictive testing for Huntington disease in the United States. Am J Hum Genet 1997;61:1326.
16. Day ED, Hashim GA, Potter NT, Lazarus KJ. Immunochemical analysis of Lewis rat antisera to the synthetic encephalitogenic peptide S49. Neurochemistry Research 1985;10:1587-1603.

Send e-mail to Nicholas T. Potter